Croda International Plc (OTCMKTS:COIHD - Get Free Report)'s stock price rose 6.3% during trading on Thursday . The company traded as high as $19.80 and last traded at $19.61. Approximately 46,662 shares traded hands during trading, an increase of 2,155% from the average daily volume of 2,069 shares. The stock had previously closed at $18.44.
Croda International Stock Performance
The firm has a market cap of $5.10 billion, a PE ratio of 15.39, a PEG ratio of 2.26 and a beta of 0.53. The company's 50-day simple moving average is $19.26 and its two-hundred day simple moving average is $21.13.
Croda International Company Profile
(
Get Free Report)
Croda International Plc creates, makes, and sells specialty chemicals in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company operates in four segments: Personal Care, Life Sciences, Performance Technologies, and Industrial Chemicals. It offers adhesives; crop protection additives and adjuvants, seed enhancement and animal health chemicals, chemical bio-stimulants, and specialty additives for agricultural films; and lubricant additives, coatings and polymers, vehicle cleaning chemicals, and products for automotive textiles and fibers, as well as specialty additives for plastics, and battery and catalyst industries.
See Also
Before you consider Croda International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Croda International wasn't on the list.
While Croda International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
